Bringing new therapeutics to patients via our unique macrocyclic drug discovery platform.
GyreOx Limited is a 2019 spinout from the University of Oxford. Incorporated on 20 May 2019, with the laboratories located at the Harwell Campus in Oxfordshire.
GyreOx’s platform technology is a combined chemistry / synthetic biology process, protected by 4 patent applications, allowing rapid access to novel and drug-like gyrocycles for hit-to-lead drug discovery.
Our proprietary discovery platform is used to create unique and highly modified macrocyclic compounds called ‘gyrocycles’. Gyrocycles combine the target-engagement power of biologics with the cell-entry ability of small molecules.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Oxford, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gyreox.com
- HQ
- Oxford
Gyreox Questions
Gyreox's website is gyreox.com
Gyreox's LinkedIn profile is https://uk.linkedin.com/company/gyreox
Gyreox has
2 employees.
View email and phone details for 2
employees at Gyreox.
Gyreox's industry is
Biotechnology Research
Gyreox's categories are Biotechnology Research
Gyreox's founding year is 2019
